Sam Eldessouky - 03 Mar 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Signature
/s/ Debra E. Levin, attorney-in-fact for Sam Eldessouky
Issuer symbol
BHC
Transactions as of
03 Mar 2022
Net transactions value
-$29,324
Form type
4
Filing time
07 Mar 2022, 16:41:22 UTC
Previous filing
02 Mar 2022
Next filing
09 May 2022

Key filing fact

Sam Eldessouky filed Form 4 for Bausch Health Companies Inc. (BHC) on 07 Mar 2022.

Key facts

  • This page summarizes Sam Eldessouky's Form 4 filing for Bausch Health Companies Inc. (BHC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 07 Mar 2022, 16:41.

Change

  • Previous filing in this sequence was filed on 02 Mar 2022.
  • Current net transaction value: -$29,324.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value
$29,324
Shares
-1,242
Change %
-1%
Price
$23.61
Shares after
119,455
Date
03 Mar 2022
Ownership
Direct
Footnotes
F1
An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id Content
F1 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Remarks:

Due to an inadvertent administrative error, the reporting person previously filed a Form 4 on March 2, 2022 reporting the vesting of performance-based Restricted Share Units ("PSUs") on February 27, 2022. The Issuer's Talent and Compensation Committee of the Board certified the performance goals applicable to these PSUs on February 14, 2022, which was the correct date on which these PSUs performance-vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .